Search
Close this search box.

New CMO, CSO at Lantheus

ARTICLE | Management Tracks

Plus: Barbara Handelin named co-CEO of Transformative Biotech, and updates from Zephyr AI, Venatorx, Glen Clova and more

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst  

May 16, 2024 10:32 PM UTC

Radiopharmaceuticals company Lantheus Holdings Inc. (NASDAQ:LNTH) named Jeffrey Humphrey as CMO and Jean-Claude Provost as CSO. Humphrey was CEO at Radd Pharmaceuticals Inc., and CMO at Magenta Therapeutics Inc. and Constellation Pharmaceuticals Inc.; Provost joined Lantheus as interim CMO in April 2022. 

Transformative Biotech LLC named Barbara Handelin as co-CEO and a director. Handelin, who will share the CEO role with co-founder Russ Hullet, was CEO at Audacity Therapeutics PBC. She is also CEO of The 90/10 Institute, which she founded. …